Herbert Loong: Don’t miss a talk by my colleague Yin Ting Cheung addressing late effects of cancer treatment
Herbert Loong shared the following post by Yin Ting Cheung, Associate Professor and Associate Director (Research), School of Pharmacy at The Chinese University of Hong Kong, on X, adding the following:
“Definitely don’t miss a talk by my CUHK Medicine, CUHK Pharmacy colleague Yin Ting Cheung, who will be addressing late effects of cancer treatment and other pertinent issues related to survivorship.”
Quoting Yin Ting Cheung’s post:
“I am excited to return to my second home, Singapore, in Dec to discuss the current evidence on late effects of cancer and directions for future research & practice.”
Source: Herbert Loong/X and Yin Ting Cheung/X
Dr. Herbert H. F. Loong is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK), with additional roles as Deputy Medical Director of the Phase 1 Clinical Trials Centre and founder of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.
Dr. Loong has co-founded key organizations like the Asia Pacific Oncology Drug Development Consortium (APODDC) and the Asia Pacific Coalition Against Lung Cancer (APCLC). His involvement in international oncology bodies, including ASCO and IASLC, underscores his commitment to advancing cancer research and treatment on a global scale.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023